Jabril R. Johnson
Research cited on:
Prostate Cancer
Affiliation: Department of Microbiology, Biochemistry, & Immunology, Morehouse School of Medicine, 720 Westview Drive, Atlanta, GA 30310, USA
Institution: Morehouse School of Medicine
ORCID: 0000-0001-5998-7733
External IDs:
Loop profile: 1465680
| SciProfiles: 2097434
| Scopus Author ID: 57208143601
| ResearcherID: AAE-5091-2019
Works: 15,
Cited by: 89,
H-index: 8
Jabril Johnson, Ph.D., is an Assistant Professor in the Department of Microbiology, Biochemistry, and Immunology at Morehouse School of Medicine. Dr. Johnson attended Howard University, where he received his doctorate in Human Genetics in 2016. He subsequently acquired college and university faculty certification through the Alliances for Graduate Education and the Professoriate (NSF-AGEP), Preparing Future Faculty (PFF), and Center for the Integration of Research, Teaching, and Learning (CIRTL) program. Dr. Johnson continued his training as a Cancer Research Training Award (CRTA) Fellow at the National Institute of Health- National Cancer Institute in Bethesda, MD, and at the Beckman Research Institute at the City of Hope in Duarte, California. His postdoctoral training and expertise encompass cancer stem cell biology during mammary carcinogenesis and vitamin D's impact on pathway signaling during prostate cancer development. A summary of Dr. Johnson's accomplishments includes: several first-author publications; active memberships in the American Society of Human Genetics (ASHG) and the American Association for Cancer Research (AACR); community outreach certificate of recognition from the City of Pasadena, California; and outstanding community service/mentorship award. Dr. Johnson's research focuses on vitamin D immunomodulatory effects, immune signaling in the prostate microenvironment, and biomarkers in men at risk for or diagnosed with prostate cancer.
Education
- Ph.D. in Human Genetics, Howard University (2010-2016)
Research Interests
Keywords:
Prostate Cancer Disparity
Cancer Genetics
Vitamin D deficiency
Immunogenetics
Topics:
Cancer Stem Cells
Immunomodulation
Prostate Cancer
Biomarkers
Professional Links
Selected Publications
Vitamin D3 may prevent prostate cancer
Johnson JR, Martini RN, Yuan YC, Woods-Burnham L, Walker M, et al. 1,25-Dihydroxyvitamin D Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line. Biology (Basel). 2024;13. doi:10.3390/biology13050346
Related Products
Products associated with this researcher's work:
NOW Supplements, Vitamin D-3 10,000 IU, Highest Potency, Structural Support*, 120 Softgels
Related to: Prostate+cancer